Holen Sie sich die Stockscreener-App
149.45
2.19%
-3.35
Schlusskurs vom Vortag:
$152.80
Offen:
$151.78
24-Stunden-Volumen:
1.35M
Relative Volume:
1.16
Marktkapitalisierung:
$11.44B
Einnahmen:
$8.10B
Nettoeinkommen (Verlust:
$599.48M
KGV:
20.20
EPS:
7.3969
Netto-Cashflow:
$971.25M
1W Leistung:
+9.83%
1M Leistung:
+23.19%
6M Leistung:
-19.59%
1J Leistung:
+10.85%
1-Tages-Spanne:
$147.97
$153.75
1-Wochen-Bereich:
$132.36
$153.84
52-Wochen-Spanne:
$66.57
$211.00
Icon Plc Stock (ICLR) Company Profile
Firmenname
Icon Plc
Sektor
Branche
Telefon
-
Adresse
-
Compare ICLR vs TMO, DHR, IDXX, A, WAT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ICLR
Icon Plc
|
149.45 | 11.70B | 8.10B | 599.48M | 971.25M | 7.3969 |
TMO
Thermo Fisher Scientific Inc
|
472.80 | 179.13B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
184.30 | 132.10B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
562.16 | 44.55B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
135.44 | 39.08B | 7.23B | 1.41B | 1.09B | 4.979 |
WAT
Waters Corp
|
365.36 | 36.96B | 3.77B | 449.25M | 240.68M | 7.8556 |
Icon Plc Stock (ICLR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-26 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2026-02-23 | Hochstufung | Jefferies | Hold → Buy |
| 2026-02-18 | Hochstufung | TD Cowen | Hold → Buy |
| 2026-02-17 | Herabstufung | Rothschild & Co Redburn | Buy → Neutral |
| 2026-02-12 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2026-02-12 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2026-01-08 | Herabstufung | Truist | Buy → Hold |
| 2025-12-15 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2025-09-09 | Herabstufung | Jefferies | Buy → Hold |
| 2025-09-03 | Hochstufung | Rothschild & Co Redburn | Neutral → Buy |
| 2025-08-21 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-07-24 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2025-04-29 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-04-14 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-04-10 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2025-03-21 | Herabstufung | Goldman | Buy → Neutral |
| 2025-01-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-10-24 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-10-14 | Eingeleitet | Redburn Atlantic | Neutral |
| 2024-09-18 | Eingeleitet | Leerink Partners | Outperform |
| 2024-06-06 | Eingeleitet | Goldman | Buy |
| 2023-12-15 | Eingeleitet | Truist | Buy |
| 2023-09-13 | Eingeleitet | TD Cowen | Outperform |
| 2023-01-17 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2023-01-13 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2022-11-09 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-09-07 | Eingeleitet | UBS | Buy |
| 2022-08-25 | Eingeleitet | Credit Suisse | Neutral |
| 2022-05-24 | Eingeleitet | Guggenheim | Buy |
| 2022-04-25 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-04-12 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2021-09-27 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-07-23 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-07-14 | Eingeleitet | Citigroup | Neutral |
| 2021-04-13 | Fortgesetzt | BofA Securities | Neutral |
| 2021-04-01 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2021-03-08 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2021-03-03 | Eingeleitet | Barclays | Equal Weight |
| 2021-03-01 | Hochstufung | UBS | Neutral → Buy |
| 2021-02-26 | Hochstufung | Truist | Hold → Buy |
| 2020-07-24 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-04-20 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-03-26 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2020-03-02 | Eingeleitet | Deutsche Bank | Hold |
| 2020-01-27 | Herabstufung | SunTrust | Buy → Hold |
| 2020-01-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-01-07 | Eingeleitet | Citigroup | Neutral |
| 2019-09-23 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-07-26 | Hochstufung | UBS | Sell → Neutral |
| 2019-01-25 | Hochstufung | Mizuho | Neutral → Buy |
| 2018-10-26 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2018-10-09 | Eingeleitet | UBS | Sell |
| 2018-04-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2018-02-15 | Bestätigt | Mizuho | Neutral |
| 2018-01-19 | Eingeleitet | Evercore ISI | Outperform |
| 2017-10-27 | Bestätigt | Barclays | Equal Weight |
| 2017-09-11 | Eingeleitet | BofA/Merrill | Buy |
| 2017-07-31 | Hochstufung | SunTrust | Hold → Buy |
| 2017-07-27 | Bestätigt | Mizuho | Neutral |
| 2017-06-29 | Hochstufung | Jefferies | Hold → Buy |
Alle ansehen
Icon Plc Aktie (ICLR) Neueste Nachrichten
Asset turnover of ICON Plc – XETR:IJF - TradingView
EBIT of ICON Plc – XETR:IJF - TradingView
ICLR Earnings Reset: What the Accounting Probe Changed - TradingView
ICON PLC (ICLR) director Kevin Francis Egan files initial Form 3 - Stock Titan
ICON PLC (ICLR) director Jeffrey Thomas Elliott files Form 3 showing no holdings - Stock Titan
ICON Stock Jumps Again After Accounting Cloud Clears, One Risk Lingers - Bez Kabli
Icon PLC: Q4 Earnings Snapshot - AOL.com
A Look at Icon PLC (ICLR) After 4.6% Gain -- GF Value $232.63 vs Price $143.90 - GuruFocus
ICON plc Experiences Valuation Adjustment Amidst Competitive Market Landscape - Markets Mojo
ICON (ICLR) Is Up 20.8% After 2026 Outlook, Buyback And Governance Shake-UpHas The Bull Case Changed? - Yahoo Finance
William Blair Maintains Icon PLC(ICLR.US) With Buy Rating - Moomoo
Icon PLC (ICLR) Stock Price, Trades & News - GuruFocus
ICLR Stock Price, Quote & Chart | ICON PLC (NASDAQ:ICLR) - ChartMill
TD Cowen raises ICON stock price target on investigation resolution By Investing.com - Investing.com UK
McIntyre Partnerships Sold Its Position in ICON Public Limited Company (ICLR). Here’s Why - Insider Monkey
symbol__ Stock Quote Price and Forecast - CNN
ICON plc Stock 12‑Month Price Target Raised to $151.47, Implies 11% Upside - TradingView
ICON plc stock (IE0005711209): Legal & General stake increase and fresh analyst context - AD HOC NEWS
BofA raises Icon stock price target to $125 on booking trends - Investing.com UK
ICON Plc (ICLR) Stock Analysis: A Strategic Play In Healthcare With 8.54% Upside Potential - DirectorsTalk Interviews
Icon Plc $ICLR Shares Bought by Legal & General Group Plc - MarketBeat
Why ICON (ICLR) Is Up 16.5% After 2025 Earnings, Accounting Issues And New 2026 Outlook – And What's Next - Sahm
TD Cowen Maintains Icon PLC(ICLR.US) With Buy Rating, Raises Target Price to $164 - 富途牛牛
MSN Money - MSN
Icon PLC Stock Historical Valuations | BSP:ICLR34 - GuruFocus
Icon PLC (BSP:ICLR34) Stock News, Headlines & Updates - GuruFocus
Icon PLC (BSP:ICLR34) Stock Earnings Transcripts - GuruFocus
Icon PLC (BSP:ICLR34) Stock Price & 30 Year Financial Data - GuruFocus
Icon PLC (BSP:ICLR34) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
Icon PLC Stock Operating Data - GuruFocus
Icon PLC (BSP:ICLR34) Stock Price, Trades & News - GuruFocus
Icon Plc Q4 Earnings Call Highlights: Key Takeaways from Recent DiscussionNegative Surprise Momentum - thelegaladvocate.com
RBC Capital raises Icon stock price target to $126 on de-risking - Investing.com UK
A Quick Look at Today's Ratings for Icon PLC(ICLR.US), With a Forecast Between $105 to $168 - 富途牛牛
Research Alert: CFRA Maintains Hold Rating On Shares Of Icon Public Limited Company - Moomoo
ICON plc: FY 2025 Shows Reset Before Reacceleration - Seeking Alpha
RBC Capital raises Icon stock price target to $126 on de-risking By Investing.com - Investing.com South Africa
Leerink Partners Downgrades Icon PLC(ICLR.US) to Hold Rating, Raises Target Price to $145 - 富途牛牛
Jefferies Maintains Icon PLC(ICLR.US) With Buy Rating, Maintains Target Price $135 - 富途牛牛
Icon PLC (ICLR) Q4 2025 Earnings Call Highlights: Strong Bookings Amid Revenue Challenges By GuruFocus - Investing.com Canada
Hybrid Clinical Research Job at ICON | Life Science Graduates Must Apply! - BioTecNika
Icon PLC (ICLR) Q4 2025 Earnings Call Highlights: Strong Bookings Amid Revenue Challenges - GuruFocus
Icon Plc Flags Material Weakness in Internal Controls, Raising Financial Reporting and Regulatory Risks - TipRanks
ICON Public Limited (ICLR) Reports Q4 Earnings Below Expectations - GuruFocus
ICON plc Stock 12‑Month Price Target Raised to $137.07, Implies 16% Upside - TradingView
Leerink raises ICON stock price target to $145 on demand outlook - Investing.com UK
Icon ends internal accounting investigation, finds it overstated revenue in prior years - Fierce Biotech
Icon Q4 Earnings Call Highlights - Yahoo Finance
Earnings call transcript: ICON plc misses EPS but beats revenue in Q4 2025 - Investing.com Australia
Deutsche Bank Adjusts ICON Price Target to $180 From $160, Maintains Buy Rating - Moomoo
Q4 2025 ICON PLC Earnings Call Transcript - GuruFocus
Finanzdaten der Icon Plc-Aktie (ICLR)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.13%
2.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):